Literature DB >> 11452027

Phosphorylation of the RNA-dependent protein kinase regulates its RNA-binding activity.

N V Jammi1, P A Beal.   

Abstract

The RNA-dependent protein kinase (PKR) is an interferon-induced, RNA-activated enzyme that phosphorylates the alpha-subunit of eukaryotic initiation factor 2 (eIF2alpha), inhibiting the function of the eIF2 complex and continued initiation of translation. When bound to an activating RNA and ATP, PKR undergoes autophosphorylation reactions at multiple serine and threonine residues. This autophosphorylation reaction stimulates the eIF2alpha kinase activity of PKR. The binding of certain viral RNAs inhibits the activation of PKR. Wild-type PKR is obtained as a highly phosphorylated protein when overexpressed in Escherichia coli. We report here that treatment of the isolated phosphoprotein with the catalytic subunit of protein phosphatase 1 dephosphorylates the enzyme. The in vitro autophosphorylation and eIF2alpha kinase activities of the dephosphorylated enzyme are stimulated by addition of RNA. Thus, inactivation by phosphatase treatment of autophosphorylated PKR obtained from overexpression in bacteria generates PKR in a form suitable for in vitro analysis of the RNA-induced activation mechanism. Furthermore, we used gel mobility shift assays, methidiumpropyl-EDTA.Fe footprinting and affinity chromatography to demonstrate differences in the RNA-binding properties of phospho- and dephosphoPKR. We found that dephosphorylation of PKR increases binding affinity of the enzyme for both kinase activating and inhibiting RNAs. These results are consistent with an activation mechanism that includes release of the activating RNA upon autophosphorylation of PKR prior to phosphorylation of eIF2alpha.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11452027      PMCID: PMC55795          DOI: 10.1093/nar/29.14.3020

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  43 in total

1.  Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon.

Authors:  E Meurs; K Chong; J Galabru; N S Thomas; I M Kerr; B R Williams; A G Hovanessian
Journal:  Cell       Date:  1990-07-27       Impact factor: 41.582

2.  Purification of double-stranded RNA-dependent protein kinase from mouse fibroblasts.

Authors:  C E Samuel; G S Knutson; M J Berry; J A Atwater; S R Lasky
Journal:  Methods Enzymol       Date:  1986       Impact factor: 1.600

3.  Substrate recognition by Escherichia coli MutY using substrate analogs.

Authors:  C L Chepanoske; S L Porello; T Fujiwara; H Sugiyama; S S David
Journal:  Nucleic Acids Res       Date:  1999-08-01       Impact factor: 16.971

4.  A type 1 phosphoprotein phosphatase active with phosphorylated Mr = 68,000 initiation factor 2 kinase.

Authors:  R Szyszka; W Kudlicki; G Kramer; B Hardesty; J Galabru; A Hovanessian
Journal:  J Biol Chem       Date:  1989-03-05       Impact factor: 5.157

5.  Adenovirus VAI RNA antagonizes the antiviral action of interferon by preventing activation of the interferon-induced eIF-2 alpha kinase.

Authors:  J Kitajewski; R J Schneider; B Safer; S M Munemitsu; C E Samuel; B Thimmappaya; T Shenk
Journal:  Cell       Date:  1986-04-25       Impact factor: 41.582

6.  A mechanism for the control of protein synthesis by adenovirus VA RNAI.

Authors:  R P O'Malley; T M Mariano; J Siekierka; M B Mathews
Journal:  Cell       Date:  1986-02-14       Impact factor: 41.582

7.  The binding of double-stranded RNA and adenovirus VAI RNA to the interferon-induced protein kinase.

Authors:  J Galabru; M G Katze; N Robert; A G Hovanessian
Journal:  Eur J Biochem       Date:  1989-01-02

8.  Autophosphorylation of the protein kinase dependent on double-stranded RNA.

Authors:  J Galabru; A Hovanessian
Journal:  J Biol Chem       Date:  1987-11-15       Impact factor: 5.157

9.  Chromomycin, mithramycin, and olivomycin binding sites on heterogeneous deoxyribonucleic acid. Footprinting with (methidiumpropyl-EDTA)iron(II).

Authors:  M W Van Dyke; P B Dervan
Journal:  Biochemistry       Date:  1983-05-10       Impact factor: 3.162

10.  RNA structure analysis using methidiumpropyl-EDTA.Fe(II): a base-pair-specific RNA structure probe.

Authors:  C P Vary; J N Vournakis
Journal:  Proc Natl Acad Sci U S A       Date:  1984-11       Impact factor: 11.205

View more
  21 in total

1.  Analysis of PKR activation using analytical ultracentrifugation.

Authors:  James L Cole
Journal:  Macromol Biosci       Date:  2010-07-07       Impact factor: 4.979

2.  Activation of the protein kinase PKR by short double-stranded RNAs with single-stranded tails.

Authors:  Xiaofeng Zheng; Philip C Bevilacqua
Journal:  RNA       Date:  2004-12       Impact factor: 4.942

3.  Molecular mechanism by which palmitate inhibits PKR autophosphorylation.

Authors:  Hyunju Cho; Shayantani Mukherjee; Pratheeba Palasuberniam; Lisa Pillow; Betul Bilgin; Catherine Nezich; S Patrick Walton; Michael Feig; Christina Chan
Journal:  Biochemistry       Date:  2011-01-24       Impact factor: 3.162

Review 4.  Activation of PKR: an open and shut case?

Authors:  James L Cole
Journal:  Trends Biochem Sci       Date:  2006-12-29       Impact factor: 13.807

5.  Viral dsRNA inhibitors prevent self-association and autophosphorylation of PKR.

Authors:  Sean A McKenna; Darrin A Lindhout; Takashi Shimoike; Colin Echeverría Aitken; Joseph D Puglisi
Journal:  J Mol Biol       Date:  2007-06-15       Impact factor: 5.469

6.  West Nile virus infection does not induce PKR activation in rodent cells.

Authors:  H Elbahesh; S V Scherbik; M A Brinton
Journal:  Virology       Date:  2011-10-07       Impact factor: 3.616

7.  Okadaic acid induces tyrosine phosphorylation of IkappaBalpha that mediated by PKR pathway in human osteoblastic MG63 cells.

Authors:  Hiroyuki Morimoto; Akiko Ozaki; Hirohiko Okamura; Kaya Yoshida; Seiichiro Kitamura; Tatsuji Haneji
Journal:  Mol Cell Biochem       Date:  2005-08       Impact factor: 3.396

8.  Expression, purification, and biochemical characterization of the antiinflammatory tristetraprolin: a zinc-dependent mRNA binding protein affected by posttranslational modifications.

Authors:  Heping Cao
Journal:  Biochemistry       Date:  2004-11-02       Impact factor: 3.162

9.  Expression and purification of recombinant tristetraprolin that can bind to tumor necrosis factor-alpha mRNA and serve as a substrate for mitogen-activated protein kinases.

Authors:  Heping Cao; Frederick Dzineku; Perry J Blackshear
Journal:  Arch Biochem Biophys       Date:  2003-04-01       Impact factor: 4.013

10.  Analysis of monomeric and dimeric phosphorylated forms of protein kinase R.

Authors:  Eric Anderson; Christine Quartararo; Raymond S Brown; Yu Shi; Xudong Yao; James L Cole
Journal:  Biochemistry       Date:  2010-02-16       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.